Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2004 1
2008 1
2011 3
2012 2
2013 1
2015 1
2016 1
2017 2
2018 1
2019 4
2020 5
2021 7
2022 9
2023 5
2024 9
2025 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

57 results

Results by year

Filters applied: . Clear all
Page 1
TET protein inhibitors: Potential and limitations.
Kaplánek R, Kejík Z, Hajduch J, Veselá K, Kučnirová K, Skaličková M, Venhauerová A, Hosnedlová B, Hromádka R, Dytrych P, Novotný P, Abramenko N, Antonyová V, Hoskovec D, Babula P, Masařík M, Martásek P, Jakubek M. Kaplánek R, et al. Among authors: jakubek m. Biomed Pharmacother. 2023 Oct;166:115324. doi: 10.1016/j.biopha.2023.115324. Epub 2023 Aug 18. Biomed Pharmacother. 2023. PMID: 37598475 Free article. Review.
Novel Mitochondria-targeted Drugs for Cancer Therapy.
Fialova JL, Raudenska M, Jakubek M, Kejik Z, Martasek P, Babula P, Matkowski A, Filipensky P, Masarik M. Fialova JL, et al. Among authors: jakubek m. Mini Rev Med Chem. 2021;21(7):816-832. doi: 10.2174/1389557520666201118153242. Mini Rev Med Chem. 2021. PMID: 33213355 Review.
Engine shutdown: migrastatic strategies and prevention of metastases.
Raudenská M, Petrláková K, Juriňáková T, Leischner Fialová J, Fojtů M, Jakubek M, Rösel D, Brábek J, Masařík M. Raudenská M, et al. Among authors: jakubek m. Trends Cancer. 2023 Apr;9(4):293-308. doi: 10.1016/j.trecan.2023.01.001. Epub 2023 Feb 15. Trends Cancer. 2023. PMID: 36804341 Free article. Review.
Epigenetic agents in combined anticancer therapy.
Kejík Z, Jakubek M, Kaplánek R, Králová J, Mikula I, Martásek P, Král V. Kejík Z, et al. Among authors: jakubek m. Future Med Chem. 2018 May 1;10(9):1113-1130. doi: 10.4155/fmc-2017-0203. Epub 2018 Apr 20. Future Med Chem. 2018. PMID: 29676175 Review.
Pigments from Filamentous Ascomycetes for Combination Therapy.
Hromádka R, Kejík Z, Jakubek M, Kaplánek R, Šandriková V, Urban M, Martásek P, Král V. Hromádka R, et al. Among authors: jakubek m. Curr Med Chem. 2019;26(20):3812-3834. doi: 10.2174/0929867325666180330091933. Curr Med Chem. 2019. PMID: 29600749 Review.
Therapeutic potential and limitations of curcumin as antimetastatic agent.
Dytrych P, Kejík Z, Hajduch J, Kaplánek R, Veselá K, Kučnirová K, Skaličková M, Venhauerová A, Hoskovec D, Martásek P, Jakubek M. Dytrych P, et al. Among authors: jakubek m. Biomed Pharmacother. 2023 Jul;163:114758. doi: 10.1016/j.biopha.2023.114758. Epub 2023 May 2. Biomed Pharmacother. 2023. PMID: 37141738 Free article. Review.
Role of mtDNA disturbances in the pathogenesis of Alzheimer's and Parkinson's disease.
Antonyová V, Kejík Z, Brogyányi T, Kaplánek R, Pajková M, Talianová V, Hromádka R, Masařík M, Sýkora D, Mikšátková L, Martásek P, Jakubek M. Antonyová V, et al. Among authors: jakubek m. DNA Repair (Amst). 2020 Jul-Aug;91-92:102871. doi: 10.1016/j.dnarep.2020.102871. Epub 2020 May 21. DNA Repair (Amst). 2020. PMID: 32502755 Review.
Iron chelators as mitophagy agents: Potential and limitations.
Brogyanyi T, Kejík Z, Veselá K, Dytrych P, Hoskovec D, Masařik M, Babula P, Kaplánek R, Přibyl T, Zelenka J, Ruml T, Vokurka M, Martásek P, Jakubek M. Brogyanyi T, et al. Among authors: jakubek m. Biomed Pharmacother. 2024 Oct;179:117407. doi: 10.1016/j.biopha.2024.117407. Epub 2024 Sep 11. Biomed Pharmacother. 2024. PMID: 39265234 Free article. Review.
Non-psychotropic cannabinoids as inhibitors of TET1 protein.
Antonyová V, Kejík Z, Brogyanyi T, Kaplánek R, Veselá K, Abramenko N, Ocelka T, Masařík M, Matkowski A, Gburek J, Abel R, Goede A, Preissner R, Novotný P, Jakubek M. Antonyová V, et al. Among authors: jakubek m. Bioorg Chem. 2022 Jul;124:105793. doi: 10.1016/j.bioorg.2022.105793. Epub 2022 Apr 6. Bioorg Chem. 2022. PMID: 35462234
57 results